echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Only 0.8% of heart tumors are primary malignancies, 5 years survival rate of less than 12%! JACC U.S. Cancer Data

    Only 0.8% of heart tumors are primary malignancies, 5 years survival rate of less than 12%! JACC U.S. Cancer Data

    • Last Update: 2020-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, national cancer data from theJACCshowed that only 0.8% of all heart tumors are primary malignancies88.5% of these primary malignancies were sarcoma, the majority of which were hemanagiomas (40.4% of all primary malignancies)The 30-day, 1-year and 5-year survival rates of patients with primary heart malignancies were 81.2%, 45.3% and 11.5%, respectivelynearly 60% (59.2%) of patients with primary malignant neoplasms received surgery, of which 57.7% underwent chemotherapy, radiotherapy or radiotherapy at the same timenearly 30 percent (29.4 percent) of patients who underwent surgery alone died within 90 daysonly 26% of patients undergoing surgery had a complete excision (R0) stateThe survival rate of these patients with clean cut edge was significantly higher than in patients who were still positive for cut edgeThe long-term survival rate of patients who underwent surgerywas significantly higher than that of those who had not been operated onIn addition, in patients with stage III lesions, the survival rate was higher among patients who received chemotherapy during the perioperative periodreview experts point out that the study shows that most patients are younger (on average, 53 years old) and need to improve treatment for primary malignancies of the heartFor these patients, the first step is to improve the surgical treatment rate, and try to achieve R0 excisionIf the tumor cannot be fully removed, multidisciplinary treatment strategies are needed, and postoperative chemotherapy or radiotherapy may help improve cure rates and improve patient prognosisthe study was included in the 2004-2016 U.SNational Cancer Database in all physical heart tumor patients, a total of about 100,000 cases of heart tumors were confirmed, of which 826 (0.8%) were primary malignancies, and eventually 747 patients, with an average age of 53 years and 47.5 percent of women136 patients with primary heart cancer were not treated, 113 were undergoing chemotherapy only, and 20 were only radiotherapySource:[1] Long-Term Outcomes of Primary Cardiac Malignancies Multi-Institutional Results From the National Cancer DatabaseJ Am Coll Cardiol, 2020, 75 (18): 2338-2347Primary Cardiac Malignances: The Need for a MMDad and the Role of The Cardio-SistJ Am Coll Cardiol, 2020, 75 (18)DOI: 10.1016/j.jacc.2020.03.046Author: Zhu Zhu Source: China Circulation Journal
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.